Dextromethorphan-quinidine is helpful for pseudobulbar affect disorder in stroke patients

An informed consent article using Hammond FM, Alexander DN, Cutler AJ, et al. PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology. 2016;16:89. https://doi.org/10.1186/s1...

Full description

Saved in:
Bibliographic Details
Published inClinical research in practice Vol. 7; no. 2
Main Authors Francis, Michael, Hamame, Mira, Nasrallah, Mariam, Nesbitt, Alison, Meza, James P.
Format Journal Article
LanguageEnglish
Published 05.11.2021
Online AccessGet full text

Cover

More Information
Summary:An informed consent article using Hammond FM, Alexander DN, Cutler AJ, et al. PRISM II: an open-label study to assess effectiveness of dextromethorphan/quinidine for pseudobulbar affect in patients with dementia, stroke or traumatic brain injury. BMC Neurology. 2016;16:89. https://doi.org/10.1186/s12883-016-0609-0 for a patient with pseudobulbar affect following stroke.
ISSN:2379-4550
2379-4550
DOI:10.22237/crp/1636070400